Skip to the main content
The Crier

UK SBS PregnAnZI-2 doubleblind clinical trial pharmaceuticals

Your saved contracts

What the buyer wrote

PregnAnZi-2 is a follow on from a smaller batch trial (PregnAnZi-1) which involved 829 patients. The new trial will involve ca. 12,500. This supplier provided the azithromycin and placebo blisters for the previous trial and therefore it is a requirement to use them again for this expanded trial.

Bid for this and lost? There is a short window in which the decision can be questioned.

Awarded to

Idifarma Desarrollo Farmaceutico SL£36.8kends (8 May 2017)

Details

What the buyer calls it
UK SBS PregnAnZI-2 doubleblind clinical trial pharmaceuticals
How they are buying
Given to one supplier, no competitionNobody else was asked, and the buyer has to be able to justify that.
Type
goods
Suitable for small firms
The buyer says yes. What that is worth
Work starts
6 Mar 2017
Work ends
8 May 2017

Who the buyer named

Rebecca Fish was the named contact on this notice.

fmprocurement@uksbs.co.uk